Metabolic Requirements during Six Minutes Walking Tests in Patients Affected by Chronic Obstructive Pulmonary Disease in Different Stages

Giuseppe Valerio, Pierluigi Bracciale, Fabio Valerio

Clinica Salus Brindisi, Brindisi, Italy.
Divisione di Pneumologia Ospedale “Ninetto Melli” San Pietro Vernotico, Brindisi, Italy.
Università Tor Vergata Roma, Brindisi, Italy.

DOI: 10.4236/ojrd.2012.24012                

Abstract

Backgrounds: In Chronic Obstructive Pulmonary Disease (COPD) a multi factorial effort limitation becomes pro- gressively relevant as the disease progresses in the consecutive stages. It is measured by both six minutes walking test (6MWT) and maximal cardiopulmonary incremental test (CPET). Aim: It is important to assess in each stage of dis-ease the metabolic load during 6MWT referring to the outcome of CPET and to ascertain whether there is a significant rela- tionship between the measures obtained by CPET and 6MWT. Methods: Four group of fifteen patients affected by COPD in stage I to IV underwent 6MWT and maximal CPET in the same day and results were compared to a group of healthy people. Airflow obstruction was measured by whole body plethysmography, blood gases by gas analysis, maxi- mal oxygen consumption and metabolic parameters by ergometer, lactic acid levels by analyzer. Results: Maximal oxygen consumption (V’O2max) and 6MWT are progressively impaired and related (V’O2max = 1.25 ? 0.26, 1.152 ? 0.4, 1.03 ? 0.44, .85 ? 0.2 l/m; 6MWD = 452 ? 84, 446 ? 82, 381 ? 165, 200 ? 100 respectively in GOLD I to IV stage). Oxygen consumption (V’O2) during 6MWT becomes stable after 3 - 4 minutes and reached at the end of the test close to those measured at de-compensated metabolic acidosis anaerobic threshold (TDMA) (85 ± 0.4 l/m vs. 9 ? 0.4 l/m) in stage I to III, while in COPD there is no difference between V’O2max and V’O2 during 6MWT (0.85 ? 0.2 vs. 0.8 ? 0.23 l/m). 6MWT is more suitable to determine oxygen desaturation than CPET (dSaO2 ?4 ± 2% vs. ?2 ± 1%). 6MWD, the workload performed in 6MWT and V’O2max are significantly related. Conclusion: 6MWT looks as a suitable sub maximal test related CPET. Metabolic requirements under 6MWT are close to TDMA and are obtained in a suitable, self paced, usual exercise, close to everyday experience and thus related to activity daily levels. As the disease worsens the differences between V’O2 during 6MWT and V’O2max wane.

Keywords

COPD; 6MWT; CPET; AT; TDMA

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	The GOLD Expert Panel, “Global Strategy for the Diagnosis and Prevention of COPD,” www.goldcopd.com
[2]	I. M. Weissman and R. J. Zeballos, “Modalities of Cinical Exercise Testing in Clinical Exercise Testing,” In: I. M. Weisman and R. J. Zeballos, Eds., Progress in Respiratory Research, Karger, Basel, 2002, pp. 31-40.
[3]	S. A. Ward and P. Palange, “Clinical Exercise Testing,” European Respiratory Society Monograph, Vol. 40, 2007, pp. 108-174.
[4]	R. O. Crapo, P. L. Enricht and R. J. Zeballos, “ATS Statement: Guidelines for the Six-Minutes Walk Test,” American Journal of Respiratory and Critical Care Medicine, Vol. 166, No. 1, 2002, pp. 111-117
[5]	M.-L. Chuang, I.-F. Lin and K. Wasserman, “The Body Weight-Walking Distance Product as Related to Lung Function, Anaerobic Threshold and Peak VO2 in COPD Patients,” Respiratory Medicine, 2001, Vol. 95, No. 7, pp. 618-626. doi:10.1053/rmed.2001.1115
[6]	A. Casas, J. Vilaro, R. Rabinovich, A. Mayer, J. A. Barberà, et al., “Encouraged 6-Min Walking Test Indicates Maximum Sustainable Exercise in COPD Patients,” Chest, Vol. 128, No. 1, 2005, PP. 55-61. doi:10.1378/chest.128.1.55
[7]	C. G. Cote, V. Pinto-Plata, K. Kaspzzyk, et al., “The Six Minute Walking Distance, Peak Oxygen Uptake and Mortality in Chronic Obstructive Pulmonary Disease,” European Respiratory Journal, Vol. 29, No. 3, 2007, pp. 535-540.
[8]	B. R. Celli, C. G. Cote, J. M. Marin, C. Casanova, M. M. de Oca, R. A. Mendez, V. Pinto-Plata and H. J. Cabral, “The Body-Mass Index, Airflow Obstruction, Dyspnea and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease,” The New England Journal of Medicine, Vol. 350, No. 10, 2004, pp. 1005-1012 doi:10.1056/NEJMoa021322
[9]	T. Troosters, J. Vilaro, R. Rabinovich, A. Casas, J. A. Barbera, R. Rodríguez-Roisin, et al., “Physiological Responses to the 6-Min Walk Test in Patients with Chronic Obstructive Pulmonary Disease,” European Respiratory Journal, Vol. 20, No. 3, 2002, pp. 564-569. doi:10.1183/09031936.02.02092001
[10]	S. E. Turner, P. R. Eastwood, N. M. Cecins, D. R. Hillman and S. C. Jenkins, “Physiologic Responses to Incremental and Self-Paced Exercise in COPD,” Chest, Vol. 126, No. 3, 2004, pp. 766-773 doi:10.1378/chest.126.3.766
[11]	C. R. Swinburn, M. Wakefield and P. W. Jones, “Performance, Ventilation, and Oxygen Consumption in Three Different Types of Exercise Test in Patients with Chronic Obstructive Lung Disease,” Thorax, Vol. 40, No. 8, 1985, pp. 581-586. doi:10.1136/thx.40.8.581
[12]	N. Luxton, J. A. Alison, J. Wu and M. G. Mackey, “Relationship between Field Walking Tests and Incremental Cycle Ergometry in COPD,” Respirology, Vol. 13, No. 6, 2008, pp. 856-862 doi:10.1111/j.1440-1843.2008.01355.x
[13]	H. A. C. van Helvoort, Y. F. Heijdra, R. C. C. de Boer, A. Swinkels, H. M. H. Thijs and P. N. R. Dekhuijzen, “Six-Minute Walking-Induced Systemic Inflammation and Oxidative Stress in Muscle-Wasted COPD Patients,” Chest, Vol. 131, No. 2, 2007, pp. 439-445. doi:10.1378/chest.06-1655
[14]	O. Díaz, A. Morales, R. Osses, J. Klaassen, C. Lisboa and F. Saldías, “Six-Minute-Walk Test and Maximum Exercise Test in Cycloergometer in Chronic Obstructive Pulmonary Disease. Are the Physiological Demands Equivalent?” Archivos de Bronconeumología, Vol. 46, No. 6, 2010, pp. 294-301.
[15]	M.-L. Chuang, I.-F. Lin and K. Wasserman, “The Body Weight-Walking Distance Product as Related to Lung Function, Anaerobic Threshold and Peak V02 in COPD Patients,” Respiratory Medicine, Vol. 95, No. 7, 2001, pp. 618-626. doi:10.1053/rmed.2001.1115
[16]	P. L. Enright, D. L. Sheril, “Reference Equations for the Six Minutes Walking Distance in Healthy Adults,” American Journal of Respiratory and Critical Care Medicine, Vol. 158, No. 5, 1998, pp. 1384-1387.
[17]	S. Solway, D. Brooks, et al., “A Qualitative Systematic Overview of the Measurement Properties of Functional Walk Tests Used in the Cardiorespiratory Domain,” Chest, Vol. 119, No. 1, 2001, pp. 256-270. doi:10.1378/chest.119.1.256
[18]	C. Incorvaia, G. C. Riario Sforza, C. Pravettoni, F. Paterniti, L. Pessina and N. Dugnani, “Assessment of Global Severity of COPD in Patients Classified by GOLD Stages Undergoing Pulmonary Rehabilitation,” Multidisciplinary Respiratory Medicine, Vol. 37, No. 2, 2006, pp. 23-27.
[19]	D. Starobin, M. Kramer, A. Yarmolovsky, B. Bendayan, “Assessment of Functional Capacity in Patients with Chronic Obstructive Pulmonary Disease: Correlation between Cardiopulmonary Exercise, 6 Minute Walk and 15 Step Exercise Oximetry Test,” Israel Medical Association Journal, Vol. 8, No. 7, 2006, pp. 460-462
[20]	T. Oga, K. Nishimura, M. Tsukino, et al., “Exercise Capacity Deterioration in Patients with COPD: Longitudinal Evaluation over 5 Years,” Chest, Vol. 128, No. 1, 2005, pp. 62-69. doi:10.1378/chest.128.1.62
[21]	T. Oga, K. Nishirnura, M. Tsukino, T. Haijro, A. Ikeda and M. Mishima, “Relationship between Different Indices of Exercise Capacity and Clinical Measures in Patients with Chronic Obstructive Pulmonary Disease,” Heart & Lung, Vol. 31, No. 5, 2002, pp. 374-381. doi:10.1067/mhl.2002.127941
[22]	K. C. Ong and Y. Y. Ong, “Cardiopulmonary Exercise Testing in Patients with Chronic Obstructive Pulmonary Disease,” Annals of Academy of Medicine, Singapore, Vol. 29, No. 5, 2000, pp. 648-652.
[23]	R. Carter, D. B. Holiday, C. Nwasuruba, J. Stocks, C. Grothucs and B. Tiep, “6-Minute Walk Work for Assessment of Functional Capacity in Patients with COPD,” Chest, Vol. 123, No. 5, 2003, pp. 1408-1415. doi:10.1378/chest.123.5.1408
[24]	N. Tojo, M. Ichioka, M. Chida, et al., “Pulmonary Exercise Testing Predicts Prognosis in Patients with Chronic Obstructive Pulmonary Disease,” Internal Medicine, Vol. 44, No. 1, 2005, pp. 20-25 doi:10.2169/internalmedicine.44.20
[25]	K. Hill and T. E. Dolmage, “Defining the Relationship between Average Daily Expenditure and Field-Based Walking Tests and Aerobic Reserve in COPD,” Chest, Vol. 141, No. 2, 2012, pp. 406-412. doi:10.1378/chest.11-0298
[26]	A. W. Vaes, F. M.Franssen, N. H.Uszko-Lencer, et al., “Task-Related Oxygen Uptake during Domestic Activities of Daily Life in Patients with COPD and Healthy Elderly Subjects,” Chest, Vol. 140, No. 4, 2011, pp. 970-979.
[27]	D. J. Lesser, M. M. Fleming, C. A. Maher, S. B. Kim, M. S. Woo and T. G. Keens, “Does the 6-Min Walk Test Correlate with the Exercise Stress Test in Children?” Pediatric Pulmonology, Vol. 45, No. 2, 2010, pp. 135-140. doi:10.1002/ppul.21125
[28]	I. Blanco, C. Villaquirán, J. L. Valera, M. Molina-Molina, A. Xaubet, R. Rodríguez-Roisin, J. A. Barberà and J. Roca, “Peak Oxygen Uptake during the Six-Minute Walk Test in Diffuse Interstitial Lung Disease and Pulmonary Hypertension,” Archivos de Bronconeumología, Vol. 46, No. 3, 2010, pp. 122-128. doi:10.1016/S1579-2129(10)70032-X
[29]	Jehn M, Halle M, Schuster T, Hanssen H, Weis M, et al., “The 6-Min Walk Test in Heart Failure: Is It a Max or Sub-Maximum Exercise Test?” European Journal of Applied Physiology, Vol. 107, No. 3, 2009, pp. 317-23. doi:10.1007/s00421-009-1128-0
[30]	P. Palange, S. Forte, P. Onorati, F. Manfredi, P. Serra and S. Carlone, “Ventilatory and Metabolic Adaptations to Walking and Cycling in Patients with COPD,” Journal of Applied Physiology, Vol. 88, No. 5, 2000, pp. 1715-1720.
[31]	M. Poulain, F. Durand, B. Palomba, F. Ceugniet, J. Desplan, A. Varray and C. Préfaut, “6-Minute Walk Testing Is More Sensitive than Maximal Incremental Cycle Testing for Detecting Oxygen Desaturation in Patients with COPD,” Chest, Vol. 123, No. 5, 2003, pp. 1401l407.
[32]	D. Hsia, R. Casaburi, A. Pradhan, E. Torres and J. Porszasz, “Physiological Responses to Linear Treadmill and Cycle Ergometer Exercise in COPD,” European Respiratory Journal, Vol. 34, No. 3, 2009, pp. 605-615. doi:10.1183/09031936.00069408
[33]	A. Aliverti, N. Stevenson, R. L. Dellacà, et al., “Regional Chest Wall Volumes during Exercise in Chronic Obstructive Pulmonary Disease,” Thorax, Vol. 59, No. 3, 2004, pp. 210-216. doi:10.1136/thorax.2003.011494
[34]	R. Reid O. Díaz, J. Jorquera and C. Lishoa, “The Six Minute Walking Test Elicits Lung Hyperinflation in Patients with Severe Chronic Obstructive Lung Disease,” Revista Médica de Chile, Vol. 129, No. 10, 2001, pp. 1171-1178.
[35]	H. A. C. van Helvoort, Y. F. Heijdra, R. C. C. de Boer, et al., “Six-Minute Walking-Induced Systemic Inflammation and Oxidative Stress in Muscle-Wasted COPD Patients,” Chest, Vol. 131, No. 2, 2007, pp. 439-445. doi:10.1378/chest.06-1655
[36]	H. F. van Stel, J. M. Bogaard and L. H. Rijssenbeek-Nouwens, “Multivariable Assessment of the 6-Min Walking Test in Patients with Chronic Obstructive Pulmonary Disease,” American Journal of Respiratory and Critical Care Medicine, Vol. 163, No. 7, 2001, pp. 1567-1571.